NCT04689503

Brief Summary

In order to provide reference for clinical application, the normal values of retinal blood flow parameters in Chinese healthy children were measured by oct-angiography. Meanwhile, the repeatability and consistency of retinal blood flow parameters measured by oct-angiography in children were further analyzed, and the correlation of retinal blood flow parameters with eye axis, choroidal thickness, age and diopter was analyzed, so as to provide basis for clinical diagnosis of children's ophthalmopathy. Objective to study the effect of short-term optical defocusing on retinal blood flow parameters, and analyze the correlation between the changes of posterior segment parameters before and after short-term optical defocusing, so as to provide the basis for the possible compensation mechanism of posterior segment optical defocusing, and further understand the possible physiological mechanism of myopia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2017

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2017

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

December 29, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 30, 2020

Completed
Last Updated

December 30, 2020

Status Verified

December 1, 2019

Enrollment Period

24 days

First QC Date

December 29, 2020

Last Update Submit

December 29, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood flow density measurement

    The vascular density was defined as the percentage of the area occupied by the vascular cavity after secondary reconstruction. The percentage of vascular lumen in macular area is automatically displayed based on the early treatment of diabetic retinopathy study (ETDRS) partition (i.e. macular area, paramacular area, temporal area, last time area, nasal area and inferior area), and the other partition method is based on the "Nine Palace" partition (i.e. central macular area, supratemporal area, superior area, Supranasal area, nasal area, infranasal area, inferior area, infratemporal area and temporal area)

    2017.05.01-2019.11.11

Secondary Outcomes (1)

  • Macular avascular area measurement

    2017.05.01-2019.11.11

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children volunteers with normal corrected visual acuity

You may qualify if:

  • The subjects should be 6-18 years old, with parents' consent and be able to abide by the experimental rules;
  • uncorrected visual acuity or spectacle corrected visual acuity ≥ 1.0, and each eye can fix the target;
  • equivalent spherical lens range + 0.50D \~ - 6.00D, binocular spherical lens anisometropia ≤ 1D, anisometropia ≤ 1.5D;
  • frame glasses can be worn for patients with ametropia, and hard contact lenses can not be worn for at least 4 weeks, and anisometropia can not be worn for 2 weeks
  • intraocular pressure in the normal range (9mmhg-21mmhg)

You may not qualify if:

  • Patients with history of ocular trauma and surgery;
  • patients with ocular organic lesions or systemic diseases;
  • patients with dry eye;
  • patients in the treatment period using drugs (such as atropine eye drops);
  • patients with poor cooperation or unqualified image quality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The affiliated Eye Hospital of Wenzhou Medical College

Wenzhou, Zhejiang, 325027, China

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
vice-president

Study Record Dates

First Submitted

December 29, 2020

First Posted

December 30, 2020

Study Start

May 1, 2017

Primary Completion

May 25, 2017

Study Completion

November 11, 2019

Last Updated

December 30, 2020

Record last verified: 2019-12

Locations